|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments (Note 2) | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, net of allowance for doubtful accounts of $29 million and $28 million, respectively (Note 2) | ||||||||||||||||||||
| Inventories (Note 3) | ||||||||||||||||||||
| Other current assets (Note 4) | ||||||||||||||||||||
| Current assets of discontinued operations (Note 21) | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Long-term assets: | ||||||||||||||||||||
| Property, net | ||||||||||||||||||||
| Operating lease, right-of-use assets | ||||||||||||||||||||
| Investments in affiliates (Note 21) | ||||||||||||||||||||
| Intangible assets, net (Note 2) | ||||||||||||||||||||
| Goodwill (Note 2) | ||||||||||||||||||||
| Other long-term assets (Note 4) | ||||||||||||||||||||
| Long-term assets of discontinued operations (Note 21) | ||||||||||||||||||||
| Total long-term assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST AND SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Short-term debt (Note 8) | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities (Note 5) | ||||||||||||||||||||
| Current liabilities of discontinued operations (Note 21) | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term liabilities: | ||||||||||||||||||||
| Long-term debt (Note 8) | ||||||||||||||||||||
| Pension benefit obligations | ||||||||||||||||||||
| Long-term operating lease liabilities | ||||||||||||||||||||
| Other long-term liabilities (Note 5) | ||||||||||||||||||||
| Long-term liabilities of discontinued operations (Note 21) | ||||||||||||||||||||
| Total long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Redeemable noncontrolling interest (Note 2) | ||||||||||||||||||||
| Preferred shares, outstanding | ||||||||||||||||||||
| Shareholders' equity: | ||||||||||||||||||||
| Preferred shares, $0.01 par value per share, 50,000,000 shares authorized, none issued and outstanding | ||||||||||||||||||||
| Ordinary shares, $0.01 par value per share, 1,200,000,000 shares authorized, 208,365,500 and 212,746,899 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss (Note 13) | ||||||||||||||||||||
| Total Aptiv shareholders' equity | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities, redeemable noncontrolling interest and shareholders' equity | ||||||||||||||||||||
| Preferred shares, issued |
Loading...